Simplify Medical completes enrollment for Simplify Disc trial at 16 US sites — 5 insights

Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.

Advertisement

Here are five insights:

 

1. The company capped enrollment at 166 patients at 16 sites across the country.

 

2. The trial is assessing the Simplify Disc for one-level cervical implantation between C3-C7.

 

3. Domagoj Coric, MD, of Charlotte-based Carolina Neurosurgery and Spine Associates, and Richard Guyer, MD, of Plano-based Texas Back Institute Foundation, are serving as national co-primary investigators.

 

4. The Simplify Disc is made mostly of PEEK-on-ceramic, allowing its visibility on MRI.

 

5. The Simplify Disc already has the CE Mark.

 

More articles on devices:
Stryker achieves 95% ownership of Vexim: 5 takeaways
Zimmer Biomet, Stryker, Smith & Nephew & more: 16 device company notes
5 things to know about Stryker CEO Kevin Lobo

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.